Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as first-line chemotherapy for metastatic pancreatic cancer by Xi Guo, MD, Yaolin Xu, MD, Yuan Ji, MD, Yue Fan, MD, Dansong Wang, MD, Dayong Jin, MD, Rongyuan Zhuang, MD, Lili Wu, MD, Wenhui Lou, MD, Yuhong Zhou, MD

Get full text